Consistent growth in outsourced biomanufacturing points to an evolving industry increasingly reliant on external capacity and expertise.
Doug Nissinoff
Advertisement
Doug Nissinoff is director, Research Projects at BioPlan Associates.
Articles by Doug Nissinoff
Advertisement
Latest Updated Articles
Growing Opportunities in Outsourced Biopharma APIsPublished: September 28th 2023 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
2
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
3
Excipient Innovation and the Regulatory Tug-of-War: Navigating Threats to Availability and Safety
4
US and European Pharma Manufacturing Face Diverging Paths to Resilience
5
